Loading clinical trials...
Loading clinical trials...
Association of Axillary Lymph Node Dissection With Oncological Outcomes in Patients With Residual Micrometastases After Neoadjuvant Chemotherapy: The OPBC-07/microNAC Study
Conditions
Locations
84
United States
Valleywise Health Medical Center
Phoenix, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of California
San Francisco, California, United States
Providence Saint John's Cancer Institute
Santa Monica, California, United States
University of Miami
Coral Gables, Florida, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
May 15, 2024
Primary Completion Date
June 1, 2025
Completion Date
June 1, 2025
Last Updated
January 24, 2025
NCT04541381
NCT03137095
NCT07547774
NCT07040891
NCT06393374
NCT06257264
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions